UFP Technologies/$UFPT
1D1W1MYTD1Y5YMAX
Capital at risk
About UFP Technologies
UFP Technologies Inc is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. The company manufactures its products by converting raw materials using laminating, molding, radio frequency, and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.
- Ticker
- $UFPT
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 4,846
- Headquarters
- Newburyport, United States
- Website
- www.ufpt.com
UFP Technologies Metrics
BasicAdvanced
$2.1B
29.99
$9.25
1.06
-
Price and volume
Market cap
$2.1B
Beta
1.06
52-week high
$338.71
52-week low
$173.86
Average daily volume
158K
Financial strength
Current ratio
3
Quick ratio
1.614
Long term debt to equity
22.664
Total debt to equity
25.367
Interest coverage (TTM)
12.38%
Profitability
EBITDA (TTM)
115.842
Gross margin (TTM)
28.50%
Net profit margin (TTM)
11.45%
Operating margin (TTM)
15.23%
Effective tax rate (TTM)
18.44%
Revenue per employee (TTM)
$130,000
Management effectiveness
Return on assets (TTM)
9.13%
Return on equity (TTM)
17.05%
Valuation
Price to earnings (TTM)
29.992
Price to revenue (TTM)
3.391
Price to book
4.65
Price to tangible book (TTM)
16.44
Price to free cash flow (TTM)
34.873
Free cash flow yield (TTM)
2.87%
Free cash flow per share (TTM)
7.955
Growth
Revenue change (TTM)
7.32%
Earnings per share change (TTM)
7.34%
3-year revenue growth (CAGR)
17.84%
10-year revenue growth (CAGR)
16.20%
3-year earnings per share growth (CAGR)
12.82%
10-year earnings per share growth (CAGR)
24.54%
What the Analysts think about UFP Technologies
Analyst ratings (Buy, Hold, Sell) for UFP Technologies stock.
Analyst projections of the future price of UFP Technologies stock.
Bulls say / Bears say
UFP Technologies delivered record Q2 2026 results with net sales up 15.1% to $174.0 million and adjusted EPS rising 17.2% to a company high of $2.92, underscoring robust demand in its MedTech platform. (SEC)
Management’s strategic investments in Dominican Republic operations are generating early operational benefits by expanding capacity and improving cost structure to support future growth. (SEC)
Sales growth was broad-based, with top five customers growing 14.7% and the remainder of the MedTech segment up 19.7%, reflecting diversified demand across customer programs. (SEC)
SG&A expenses increased 21.8% year-over-year to $22.8 million, rising to 13.1% of sales due to back-office and senior management hires, weighing on operating margins. (SEC)
Full realization of benefits from Dominican Republic capacity expansion is taking longer than originally anticipated, creating short-term mix and margin headwinds in U.S. operations. (SEC)
Volatile oil prices resulting from the conflict in Iran are inflating petroleum-based raw material costs, introducing uncertainty to margin stability despite management’s expectation to pass through increases. (SEC)
Data summarised monthly by Lightyear AI. Last updated on 31 Aug 2026.
UFP Technologies Financial Performance
Revenues and expenses
UFP Technologies Earnings Performance
Company profitability
Upcoming events
No upcoming events
UFP Technologies News
AllArticlesVideos

UFP Technologies Targets 12%-18% Growth as Medical Device M&A Pipeline Builds
MarketBeat2 weeks ago

UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the 17th Annual Midwest IDEAS Investor Conference on August 26th in Chicago, IL
Business Wire3 weeks ago

UFP Technologies Q2 Earnings Call Highlights
MarketBeat1 month ago
Funds containing UFP Technologies
AllUSDGBPEUR
Fund name | Fund size | $UFPT weighting |
|---|---|---|
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.11% |
iShares S&P Small Cap 600£ISP6 | £2.4B | 0.11% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.07% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.04% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | £2.4B | 0.04% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.